Wealthcare Advisory Partners LLC and Wellington Management Group LLP have increased their stakes in The Cigna Group. Piper Sandler has initiated the coverage of Cigna with an Overweight recommendation, valuing its potential growth in the long-term. Notable share sales have also occurred, such as Brian C. Evanko selling 4,795 shares of the company. With Q1 2024 earnings surpassing EPS estimates despite hardships, analysts suggest Cigna's Specialty Pharmacy leadership could drive long-term EPS growth. Cigna's recent activities such as declaring its quarterly dividend, a $3.2 Billion accelerated stock repurchase, and preparing to sell its Medicare businesses and CareAllies to Health Care Service Corporation, signal the company's aggressive growth strategies. Cigna also plans to add three biosimilars to NPF to enable cost savings and announces significant increases to its Share Repurchase Program of $10 Billion. A considerable number of financial advisors and groups have shown interest in Cigna, adding or reducing its stocks to their portfolios.
The Cigna Group CI News Analytics from Thu, 02 Nov 2023 07:00:00 GMT to Sun, 30 Jun 2024 16:57:22 GMT -
Rating 8
- Innovation 6
- Information 5
- Rumor 0
